"Genscript"

Supplier: Genscript

Adeno-associated virus type 2 (AAV2) is a valuable vector for gene therapy. It is one member of the human parvovirus family which depends on co-infection with helper viruses such as adenovirus or herpes virus for efficient reproduction. The AAV2 capsid (intact particle) comprises three types of subunits, VP1, VP2, and VP3, a total of 60 copies in a ratio of 1:1:8 (VP1:VP2:VP3). For the application of AAV2 vector in gene therapy, the determination of total capsid titer is essential, accurate characterization and quantification of purified AAV2 particle product represent a critical step for clinical application. GenScript Anti-AAV2 (intact particle) Antibody (2C4), mAb, Mouse is produced from cell culture in vitro under conditions free from animal-derived components.

Supplier: Genscript

Etanercept with trade name Enbrel, is an FDA-approved drug to treat rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. Etanercept is a fusion protein made from the combination of two naturally occurring soluble human 75-kilodalton TNF receptors linked to an Fc portion of an IgG1. Etanercept treats autoimmune diseases by interfering with tumor necrosis factor-alpha (TNF alpha, a soluble inflammatory cytokine) by acting as a TNF alpha inhibitor.Anti-Etanercept Antibody (4H1), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Etanercept.

Supplier: Genscript

The product is specific for sarilumab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A02043-40, anti-sarilumab antibody (23H12), mAb, mouse.

Supplier: Genscript

The product is specific for Rituximab. The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01969-40, Anti-Rituximab Antibody (6C1), mAb, Mouse.

Supplier: Genscript

Panitumumab with trade name Vectibix, is an FDA-approved drug for the treatment of patients with EGFR-expressing metastatic colorectal carcinoma with non-mutated (wild-type) KRAS after failure of fluoropyrimidine-, oxaliplatin- and irinotecan-containing chemotherapy regimens. It is a human monoclonal antibody. Panitumumab binds to the human EGF receptor (EGFR), preventing binding of activating ligands, such as the EGF and transforming growth factor alpha. Anti-Panitumumab antibody (9G12), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with panitumumab.

Supplier: Genscript

The product is specific for tocilizumab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01979-40, anti-tocilizumab antibody (6C10), mAb, mouse.

Supplier: Genscript

The product is specific for Adalimumab. This antibody blocks Adalimumab binding with TNF-α (Z01001, TNF-α, Human) in ELISA. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01922-40, MonoRabTM Anti-Adalimumab Antibody (134D5), mAb, Rabbit.

Supplier: Genscript

GenScript Anti-Rabbit IgG Antibody (M205) only reacts with native rabbit IgG and does not bind to the denatured or reduced rabbit IgG heavy chain or light chain. The monoclonal antibody has no cross-reactivity with mouse, rat, bovine, goat, or sheep immunoglobulins and limited cross-reactivity with human immunoglobulins.

Supplier: Genscript

Claudin-18 is a protein that in humans is encoded by the CLDN18 gene. CLDN18 belongs to the large claudin family of proteins, which form tight junction strands in epithelial cells. The expression of isoform A2 (CLDN18.2) is restricted to the stomach mucosa where it is predominantly observed in the epithelial cells of the pit region and the base of the gastric glands including exocrine and endocrine cells (at protein level). However, CLDN18.2 is highly expressed in certain primary malignant tumors, such as gastric cancer (GC), breast cancer, colon cancer and liver cancer. CLDN18.2 is expressed in 50 - 70% of primary gastric adenocarcinomas and their metastases, thus it is considered a promising candidate for targeted gastric cancer therapy. Therapeutic antibodies against Claudin 18.2 have great therapeutic potential and very low toxicity.

Supplier: Genscript

WB-MASTER Protein Standard, Designed for convenient protein identification in western blot, Consists of 7 recombinant proteins with MW of 20-120KDa, Volume: 2.5-10 ul/well, the loading volume of the marker should be optimized for different experiments, Size: 250ul

Supplier: Genscript

The product is specific for Pembrolizumab. Thisantibody blocks Pembrolizumab binding with human PD-1 recombinant protein(Z03370, PD 1 Fc Chimera, Human) in ELISAs.

Supplier: Genscript

The product is specific for Obinutuzumab. This antibody serves as an excellent positive control for Obinutuzumab immunogenicity (ADA) assays.

Supplier: Genscript

THE™ V5 Tag antibody, mAb, Mouse recognizes C-terminal, N-terminal and internal V5 tagged fusion proteins.

Supplier: Genscript

Adeno-associated virus type 8 (AAV8) is a valuable vector for gene therapy. It is one member of the human parvovirus family which depends on co-infection with helper viruses such as adenovirus or herpes virus for efficient reproduction. AAV8 empty capsids are composed of three proteins, VP1, VP2 and VP3 with relative molecular masses of 87, 72 and 62 kDa, respectively.

Supplier: Genscript

AmMag MR-mini magnetic separation rack enables small-scale separation of magnetic beads. The rack is designed to separate paramagnetic beads from solutions contained in 1.5 mL and 2 mL micro-centrifuge tubes. The magnetic field has been optimized for separation of

Supplier: Genscript

THE™ NWSHPQFEK Tag antibody, mAb, Mouse recognizes NWSHPQFEK tags localized at the N-terminal
and C-terminal region of Strep II-tagged fusion proteins.